相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Clinical significance and immunogenomic landscape analyses of the immune cell signature based prognostic model for patients with breast cancer
Shiyuan Wang et al.
BRIEFINGS IN BIOINFORMATICS (2021)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Enrichment and detection method for the prognostic value of circulating tumor cells in ovarian cancer: A meta-analysis
Chengying Huang et al.
GYNECOLOGIC ONCOLOGY (2021)
Heterogeneous Manifestations of Epithelial-Mesenchymal Plasticity of Circulating Tumor Cells in Breast Cancer Patients
Liubov A. Tashireva et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Hexokinase 2 discerns a novel circulating tumor cell population associated with poor prognosis in lung cancer patients
Liu Yang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)
Progress and application of circulating tumor cells in non-small cell lung cancer
Huizhu Qian et al.
MOLECULAR THERAPY-ONCOLYTICS (2021)
Ubiquitin Conjugating Enzyme E2 H (UBE2H) Is Linked to Poor Outcomes and Metastasis in Lung Adenocarcinoma
Meng-Chi Yen et al.
BIOLOGY-BASEL (2021)
Epithelial-Mesenchymal-Transition-Like Circulating Tumor Cell-Associated White Blood Cell Clusters as a Prognostic Biomarker in HR-Positive/HER2-Negative Metastatic Breast Cancer
Xiuwen Guan et al.
FRONTIERS IN ONCOLOGY (2021)
The curious phenomenon of dual-positive circulating cells: Longtime overlooked tumor cells
Carolina Reduzzi et al.
SEMINARS IN CANCER BIOLOGY (2020)
Metabolic classification of circulating tumor cells as a biomarker for metastasis and prognosis in breast cancer
Jing Chen et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2020)
Inflammation-Based Scores Increase the Prognostic Value of Circulating Tumor Cells in Primary Breast Cancer
Svetlana Miklikova et al.
CANCERS (2020)
Epithelial/Mesenchymal Characteristics and PD-L1 Co-Expression in CTCs of Metastatic Breast Cancer Patients Treated with Eribulin: Correlation with Clinical Outcome
Hara Polioudaki et al.
CANCERS (2020)
Key steps for effective breast cancer prevention
Kara L. Britt et al.
NATURE REVIEWS CANCER (2020)
Presence of Circulating Tumor Cells in High-Risk Early Breast Cancer During Follow-Up and Prognosis
Elisabeth Trapp et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2019)
The clinical use of circulating tumor cells (CTCs) enumeration for staging of metastatic breast cancer (MBC): International expert consensus paper
Massimo Cristofanilli et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2019)
Circulating Tumor Cells With Epithelial-to-mesenchymal Transition Phenotypes Associated With Inferior Outcomes in Primary Breast Cancer
Michal Mego et al.
ANTICANCER RESEARCH (2019)
Circulating biomarkers for early detection and clinical management of colorectal cancer
Maria Marcuello et al.
MOLECULAR ASPECTS OF MEDICINE (2019)
Incorporating MicroRNA into Molecular Phenotypes of Circulating Tumor Cells Enhances the Prognostic Accuracy for Patients with Metastatic Breast Cancer
Weige Tan et al.
ONCOLOGIST (2019)
Epithelial-type systemic breast carcinoma cells with a restricted mesenchymal transition are a major source of metastasis
Xiao Liu et al.
SCIENCE ADVANCES (2019)
Prognostic Significance of TWIST1, CD24, CD44, and ALDH1 Transcript Quantification in EpCAM-Positive Circulating Tumor Cells from Early Stage Breast Cancer Patients
Areti Strati et al.
CELLS (2019)
Circulating Tumor Cell-Neutrophil Tango along the Metastatic Process
Massimo Saini et al.
CANCER RESEARCH (2019)
An update: circulating tumor cells in head and neck cancer
Arutha Kulasinghe et al.
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2019)
The prognostic role of circulating tumor cells in colorectal cancer
Lahiri Kanth Nanduri et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2019)
Circulating Tumor Cells with Stemness and Epithelial-to-Mesenchymal Transition Features Are Chemoresistant and Predictive of Poor Outcome in Metastatic Breast Cancer
Maria A. Papadaki et al.
MOLECULAR CANCER THERAPEUTICS (2019)
Spectrum of Epithelial-Mesenchymal Transition Phenotypes in Circulating Tumour Cells from Early Breast Cancer Patients
Aleksandra Markiewicz et al.
CANCERS (2019)
The prognostic and therapeutic implications of circulating tumor cell phenotype detection based on epithelial-mesenchymal transition markers in the first-line chemotherapy of HER2-negative metastatic breast cancer
Xiuwen Guan et al.
CANCER COMMUNICATIONS (2019)
P2Y2 receptor promotes the migration and invasion of breast cancer cells via EMT-related genes Snail and E-cadherin
Ying Qiu et al.
ONCOLOGY REPORTS (2018)
Epithelial Mesenchymal Transition in Tumor Metastasis
Vivek Mittal
ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 13 (2018)
The emerging roles of the polycistronic miR-106b ∼ 25 cluster in cancer - A comprehensive review
Dawid Mehlich et al.
BIOMEDICINE & PHARMACOTHERAPY (2018)
Impact of circulating tumour cells on survival of eribulin-treated patients with metastatic breast cancer
Mayuko Ito et al.
MEDICAL ONCOLOGY (2018)
Epithelial-to-mesenchymal transition in cancer: complexity and opportunities
Yun Zhang et al.
FRONTIERS OF MEDICINE (2018)
Association of Circulating Tumor Cells With Late Recurrence of Estrogen Receptor-Positive Breast Cancer A Secondary Analysis of a Randomized Clinical Trial
Joseph Sparano et al.
JAMA ONCOLOGY (2018)
Analysis of circulating tumour cell and the epithelial mesenchymal transition (EMT) status during eribulin-based treatment in 22 patients with metastatic breast cancer: a pilot study
Yoshiya Horimoto et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2018)
Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline
Lyndsay N. Harris et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Metastatic colonization by circulating tumour cells
Joan Massague et al.
NATURE (2016)
Potential role of nuclear PD-L1 expression in cell-surface vimentin positive circulating tumor cells as a prognostic marker in cancer patients
Arun Satelli et al.
SCIENTIFIC REPORTS (2016)
In patients with metastatic breast cancer the identification of circulating tumor cells in epithelial-to-mesenchymal transition is associated with a poor prognosis
Michela Bulfoni et al.
BREAST CANCER RESEARCH (2016)
Relationship between circulating tumor cells and epithelial to mesenchymal transition in early breast cancer
M. Mego et al.
BMC CANCER (2015)
Circulating tumour cell-derived plastin3 is a novel marker for predicting long-term prognosis in patients with breast cancer
H. Ueo et al.
BRITISH JOURNAL OF CANCER (2015)
Implications of the hybrid epithelial/mesenchymal phenotype in metastasis
Mohit Kumar Jolly et al.
FRONTIERS IN ONCOLOGY (2015)
Epithelial-Mesenchymal Transitioned Tumor Cells Capture for Detecting Tumor Progression
Arun Satelli et al.
CLINICAL CANCER RESEARCH (2015)
Circulating Tumor Cell Enumeration with a Combination of Epithelial Cell Adhesion Molecule and Cell-Surface Vimentin-Based Methods for Monitoring Breast Cancer Therapeutic Response
Arun Satelli et al.
CLINICAL CHEMISTRY (2015)
Hypoxia and the extracellular matrix: drivers of tumour metastasis
Daniele M. Gilkes et al.
NATURE REVIEWS CANCER (2014)
Plastin3 Is a Novel Marker for Circulating Tumor Cells Undergoing the Epithelial-Mesenchymal Transition and Is Associated with Colorectal Cancer Prognosis
Takehiko Yokobori et al.
CANCER RESEARCH (2013)
Circulating Breast Tumor Cells Exhibit Dynamic Changes in Epithelial and Mesenchymal Composition
Min Yu et al.
SCIENCE (2013)
Mesenchymal and stemness circulating tumor cells in early breast cancer diagnosis
Guislaine Barriere et al.
BMC CANCER (2012)
A dynamic in vivo model of epithelial-to-mesenchymal transitions in circulating tumor cells and metastases of breast cancer
A. Bonnomet et al.
ONCOGENE (2012)
Depression and Risk of Stroke A Meta-Analysis of Prospective Studies
Jia-Yi Dong et al.
STROKE (2012)
Prognostic Value of EMT-Circulating Tumor Cells in Metastatic Breast Cancer Patients Undergoing High-Dose Chemotherapy with Autologous Hematopoietic Stem Cell Transplantation
Michal Mego et al.
JOURNAL OF CANCER (2012)
Expression of stem cell and epithelial-mesenchymal transition markers in primary breast cancer patients with circulating tumor cells
Sabine Kasimir-Bauer et al.
BREAST CANCER RESEARCH (2012)
Epithelial to mesenchymal transition markers expressed in circulating tumour cells of early and metastatic breast cancer patients
Galatea Kallergi et al.
BREAST CANCER RESEARCH (2011)
Meta-analysis Shows That Detection of Circulating Tumor Cells Indicates Poor Prognosis in Patients With Colorectal Cancer
Nuh N. Rahbari et al.
GASTROENTEROLOGY (2010)
Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features
Chad J. Creighton et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Practical methods for incorporating summary time-to-event data into meta-analysis
Jayne F. Tierney et al.
TRIALS (2007)
Circulating tumor cells, disease progression, and survival in metastatic breast cancer
M Cristofanilli et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Epithelial-mesenchymal transitions in tumour progression
JP Thiery
NATURE REVIEWS CANCER (2002)
分享论文
